Search Results for “ cardiovascular ” – Page 38 – media

NAFLD Aggravated by Even Modest Alcohol Use

A longitudinal cohort study published in the Clinical Gastroenterology and Hepatology revealed that non-alcoholic fatty liver disease (NAFLD) patients who consumed modest amounts of alcohol had notably low improvement in steatosis and significantly lower chances of recovery of non-alcoholic steatohepatitis (NASH), contrasted with non-drinkers.
- Source: MDEdge
- 630
- August 7, 2018
non-alcoholic fatty liver disease Researches
Tendyne Mitral Valve Replacement System U.S. Pivotal Trial Started by Abbott

A pivotal clinical study in the U.S. on the Tendyne Transcatheter Mitral Valve Replacement (TMVR) system for treating mitral regurgitation has been commenced by Abbott.
- Source: MPO Mag
- 1,132
- July 31, 2018
Abbott Clinical Trials heart valves medical device
Takeda CEO Aims to Make China Second-Largest Business in Future

Takeda CEO Christophe Weber aspires to make China its second most important market in the long run, accepting it as a major task in the future.
- Source: FiercePharma
- 876
- July 22, 2018
China Market Views Takeda
FDA Clearance for Algorithm that Quantifies Coronary Artery Calcification

Kibbutz Shefayim from an Israel-based startup company named Zebra Medical Vision announced that it has successfully received FDA clearance for an algorithm, which could aid physicians to quantify a patient’s coronary artery calcification.
- Source: MobiHealthNews
- 725
- July 13, 2018
coronary arteries FDA New Approvals
Re-Investigation on FDA Approved Anti-Gout Drug Uloric

When the FDA approved this drug, there was an additional demand from the FDA to conduct post-marketing studies and assess the drug’s safety. Recently, a non-profit consumer advocacy group sent a petition requesting that the FDA should eliminate the drug from the U.S. pharma market since the drug shows significant risk of cardiovascular diseases.
- Source: FiercePharma
- 684
- June 25, 2018
cardiovascular disease Clinical Trials gout Takeda
Can Marriage Save You From Heart Disease?

The potential reasons behind the effect of marriage include better financial security, prompt recognition of health issues and taking right action thereby improving the overall condition of a person.
- Source: Medical News Today
- 639
- June 22, 2018
heart disease Researches
Heart Risk to be Detected by CRISPR

A new risk assessment tool combining gene editing technology CRISPR-Cas9 with stem cells using disease modeling techniques has been developed by a team of scientists at the Stanford University Cardiovascular Institute. The tool has facilitated the modeling of individual patients’ heart in a lab and enabled undertaking of tests to ascertain whether or not signs of diseases are displayed by cardiac cells, as per a statement by the American Heart Association.
- Source: Fierce Biotech
- 652
- June 19, 2018
American Heart Association CRISPR-Cas9 Researches
Fixing Wrinkly Cells Via a Virus

For instance, the liver becomes accumulated with fat as we age due to wrinkly nuclear membranes. The nuclear membranes become wrinkled due to the absence of a particular membrane protein called lamin. This condition leads to high risk of type 2 diabetes, cardiovascular disease and death. If lamin becomes well structured, the scientists believe that they could cure the issue wrinkling.
- Source: Biotecnika
- 551
- June 14, 2018
aging Researches virus
Discovery of Fat Burner Hormone

It was great news in the field of medicine when geneticists from University of California, Los Angeles (UCLA) created a novel technique to hunt for natural hormones that would enhance cell communication to play a major role in treating obesity, diabetes and cardiovascular diseases. Scientists discovered two hormones called "notum" and "lipocalin-5", which would aid in the fat burning process. Lipocalin-5 also enhances metabolism and absorption of dietary nutrients by reducing the risk of diabetes and obesity.
- Source: medicalxpress
- 598
- June 8, 2018
diabetes obesity Researches
Hospira Inc. Recalls Opioid Antidote Naloxone

According to the FDA, if the antidote drugs are used on a patient, they could suffer from “allergic reactions, local irritation” and a wide number of cardiovascular issues, including restriction of blood supply to tissues. The FDA stated that there has not yet been any reports of patient harm from Naloxone.
- Source: Ddu
- 610
- June 7, 2018
Company Insights FDA opioid

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.